Eva Bøge has a MScPharm and a Master in Industrial Drug Development from University of Copenhagen and more than 13 years of pharma industry experience from Lundbeck and Leo Pharma with solid knowledge about the entire product life cycle and value chain. Eva has several years’ experience as Global Regulatory Strategy Leader responsible for global regulatory strategies and operational company deliverables for early and late-stage development projects, as well as US NDA activities incl. FDA Advisory Committee preparation and execution. Eva is currently the Regulatory Lead for a late stage development project within a paediatric orphan indication at Zealand Pharma.

Trine Moulvad has an MSc from University of Copenhagen, Denmark. She is an all-round experienced drug developer and leader with more than 25 years of experience within the pharmaceutical industry. She previously worked at Eli Lilly, Ferring and Novo Nordisk in global Regulatory leadership capacities, and have most recently gained experience from the 'small business' world of biotech at Zealand Pharma heading up Regulatory, Pharmacovigilance and Medical Writing accountable for successful Agency negotiations and taking projects from early development through to regulatory submission and approval in both US and EU. Engaged in trade associations as well as teaching and course leadership for DIA and other training organizations.